Thomas Flaten
Stock Analyst at Lake Street
(4.41)
# 1,225
Out of 4,988 analysts
354
Total ratings
49%
Success rate
9.2%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AQST Aquestive Therapeutics | Reiterated: Buy | $6 | $4.61 | +30.15% | 38 | Sep 17, 2026 | |
| ATHE Alterity Therapeutics | Initiated Coverage: Buy | $10 | $3.91 | +155.75% | 1 | Sep 15, 2026 | |
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $9 | $1.28 | +603.13% | 4 | Sep 15, 2026 | |
| BLFS BioLife Solutions | Reiterated: Hold | $31 | $36.69 | -15.51% | 28 | Sep 9, 2026 | |
| VRCA Verrica Pharmaceuticals | Reiterated: Buy | $9 | $4.45 | +102.25% | 1 | Aug 28, 2026 | |
| EVAX Evaxion | Reiterated: Buy | $9 | $3.27 | +175.23% | 26 | Aug 21, 2026 | |
| PSNL Personalis | Reiterated: Hold | $16 | $16.40 | -0.91% | 32 | Aug 21, 2026 | |
| HROW Harrow | Reiterated: Buy | $60 | $33.08 | +81.38% | 20 | Aug 20, 2026 | |
| AEON AEON Biopharma | Reiterated: Buy | $1 | $0.2425 | +312.37% | 2 | Aug 19, 2026 | |
| IMDX Insight Molecular Diagnostics | Reiterated: Buy | $12 | $4.03 | +197.77% | 26 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.12 | +525.00% | 9 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $57 | $35.34 | +61.29% | 25 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $6.85 | +104.38% | 23 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $2.12 | +230.19% | 6 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $7.31 | +77.84% | 15 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $5 | $0.63 | +693.65% | 14 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $13.24 | +81.27% | 1 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $29.20 | +36.99% | 14 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $7.98 | +37.84% | 30 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $22.65 | +120.75% | 5 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.60 | n/a | 15 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 | $0.0001 | n/a | 8 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 → $15 | $0.4581 | n/a | 3 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 | $1.20 | n/a | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $50 | $39.80 | n/a | 4 | Mar 1, 2022 |
Aquestive Therapeutics
Sep 17, 2026
Reiterated: Buy
Price Target: $6
Current: $4.61
Upside: +30.15%
Alterity Therapeutics
Sep 15, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $3.91
Upside: +155.75%
Connect Biopharma Holdings
Sep 15, 2026
Reiterated: Buy
Price Target: $9
Current: $1.28
Upside: +603.13%
BioLife Solutions
Sep 9, 2026
Reiterated: Hold
Price Target: $31
Current: $36.69
Upside: -15.51%
Verrica Pharmaceuticals
Aug 28, 2026
Reiterated: Buy
Price Target: $9
Current: $4.45
Upside: +102.25%
Evaxion
Aug 21, 2026
Reiterated: Buy
Price Target: $9
Current: $3.27
Upside: +175.23%
Personalis
Aug 21, 2026
Reiterated: Hold
Price Target: $16
Current: $16.40
Upside: -0.91%
Harrow
Aug 20, 2026
Reiterated: Buy
Price Target: $60
Current: $33.08
Upside: +81.38%
AEON Biopharma
Aug 19, 2026
Reiterated: Buy
Price Target: $1
Current: $0.2425
Upside: +312.37%
Insight Molecular Diagnostics
Aug 18, 2026
Reiterated: Buy
Price Target: $12
Current: $4.03
Upside: +197.77%
Aug 10, 2026
Reiterated: Buy
Price Target: $7
Current: $1.12
Upside: +525.00%
Jul 31, 2026
Reiterated: Buy
Price Target: $52 → $57
Current: $35.34
Upside: +61.29%
Jun 23, 2026
Reiterated: Buy
Price Target: $14
Current: $6.85
Upside: +104.38%
May 14, 2026
Reiterated: Buy
Price Target: $8 → $7
Current: $2.12
Upside: +230.19%
May 14, 2026
Reiterated: Buy
Price Target: $13
Current: $7.31
Upside: +77.84%
May 14, 2026
Reiterated: Buy
Price Target: $9 → $5
Current: $0.63
Upside: +693.65%
May 8, 2026
Reiterated: Buy
Price Target: $24
Current: $13.24
Upside: +81.27%
May 5, 2026
Reiterated: Buy
Price Target: $40
Current: $29.20
Upside: +36.99%
Apr 15, 2026
Reiterated: Buy
Price Target: $11
Current: $7.98
Upside: +37.84%
Mar 25, 2026
Reiterated: Buy
Price Target: $50
Current: $22.65
Upside: +120.75%
May 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.60
Upside: n/a
Nov 29, 2023
Reiterated: Buy
Price Target: $1.5
Current: $0.0001
Upside: n/a
Apr 12, 2023
Reiterated: Buy
Price Target: $96 → $15
Current: $0.4581
Upside: n/a
Sep 16, 2022
Reiterated: Buy
Price Target: $3.5
Current: $1.20
Upside: n/a
Mar 1, 2022
Reiterated: Buy
Price Target: $60 → $50
Current: $39.80
Upside: n/a